Bio-equivalence Study Between SAPHRIS and Asenapine

NCT01948024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: SAPHRIS
DRUG: Asenapine

Sponsor

Sun Pharmaceutical Industries Limited

Collaborators

[object Object]